CRNX

CRINETICS PHARMACEUTICALS INC

Healthcare | Mid Cap

-$1.20

EPS Forecast

$7.55

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

-$1.20

Revenue Forecast:

$7.55

EPS Surprise Forecast:

$0.005

Revenue Surprise Forecast:

$0

Post-release price volatility - High

Post-release Overnight Move:

±9.1%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

54%

Probability of beating revenue consensus:

52%

Probability of beating both EPS & revs consensus:

34%

Probability of missing both EPS & revs consensus:

28%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-4

Beta (β)

Forward Looking Beta (β):

0.72

Earnings volatility

EPS standard deviation:

$0.44

Revenue standard deviation:

$14

As % of share price:

1.22% VERY HIGH

As % of market cap:

0.38% LOW

Confidence intervals and percentiles

EPS 95th %ile:

-$0.63

Revenue 95th %ile:

$26

EPS 75th %ile:

-$1.05

Revenue 75th %ile:

$13

EPS 25th %ile:

-$1.32

Revenue 25th %ile:

$3

EPS 5th %ile:

-$1.67

Revenue 5th %ile:

-$8

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

38% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

100% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$18

Bid-ask per Share:

$0.065